Tema ETFs
CRVS icon

Tema ETFs’s Corvus Pharmaceuticals CRVS Stock Holding History

Tema ETFs’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.68M Buy
145,642
+9,366
+7% +$130K 0.06% 212
2026
Q2 		$2.04M Buy
136,276
+28,501
+26% +$396K 0.07% 185
2026
Q1 		$1.58M Buy
107,775
+28,077
+35% +$448K 0.11% 176
2025
Q4 		$614K Buy
79,698
+20,496
+35% +$162K 0.05% 326
2025
Q3 		$436K Buy
+59,202
New +$303K 0.04% 401

Other funds holding CRVS

Jackson Square Capital
Jackson Square Capital San Francisco, California $667M AUM 118.76% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Avity Investment Management
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.61B AUM 22.22% 1-Year Est. Return
Western Pacific Wealth Management
Western Pacific Wealth Management Lake Forest, Illinois $119M AUM 20.8% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Tema ETFs's CRVS Position: Q3 2026 in Review

Tema ETFs increased its Corvus Pharmaceuticals (CRVS) stake by 6.9% in Q3 2026, buying an estimated $130K and bringing the position to 145,642 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #212.

Tema ETFs first reported a position in CRVS in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.04M in Q2 2026. 13 funds tracked by Wall St. Rank hold CRVS as of Q3 2026.

  • Tema ETFs held 145,642 shares of Corvus Pharmaceuticals worth $1.68M as of Q3 2026.
  • Tema ETFs bought 9,366 Corvus Pharmaceuticals shares in Q3 2026, an estimated $130K.
  • Corvus Pharmaceuticals made up 0.06% of Tema ETFs's portfolio in Q3 2026, its #212 holding.
  • Tema ETFs first reported a position in Corvus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Tema ETFs's Corvus Pharmaceuticals position peaked at $2.04M in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.